Ciprocinonide
Clinical data | |
---|---|
Other names | RS-2386; Fluocinolone acetonide 21-cyclopropylcarboxylate; 6α,9α-Difluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-cyclopropanecarboxylate; 6α,9α-Difluoro-11β,21-dihydroxy-16α,17α-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione 21-cyclopropanecarboxylate |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard | 100.055.715 |
Chemical and physical data | |
Formula | C28H34F2O7 |
Molar mass | 520.570 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Ciprocinonide (developmental code name RS-2386), also known as fluocinolone acetonide cyclopropylcarboxylate, is a synthetic glucocorticoid corticosteroid which was never marketed.[1]
References
- ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 282–. ISBN 978-1-4757-2085-3.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.